INSIGHTS AT POLARIS: Expert advice, news, and what's new at Polaris.
On November 15, 2016 Teva announced that it is in “advanced discussions” with the DOJ and the SEC to settle investigations into alleged violations of the Foreign Corrupt Practices Act (the FCPA) and that it set aside a $520 millionLearn More
The Third Annual Global Compliance Congress for Life Sciences took place November 16-17 in London. Polaris representatives attended the conference that addressed many important issues facing pharmaceutical, biotech and medical deviceRead more
Polaris is pleased to provide compliance and transparency developments and updates that took place in Q3 that may have an impact on your business: OUS Anti-Bribery/Anti-Corruption and Foreign Corruption PracticesRead more
Since 2001, the world's most recognized pharmaceutical, biotech and medical device companies have relied on Polaris to deliver innovative solutions for their toughest healthcare compliance challenges. Now the secret isRead more